Improving Rates of Diagnostic Colonoscopy in Native Americans

NCT ID: NCT07115875

Last Updated: 2025-09-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

164 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-12-31

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Colorectal cancer (CRC) is the second-leading cause of cancer death in both men and women in the United States. Compared to national averages, Native Americans (NA) endure a disproportionate burden of CRC incidence and CRC-specific mortality. The long-term goal of this collaboration is to enhance health equity through the reduction of CRC disparities in morbidity, mortality, stage-at-diagnosis, and survival among NA. To do so, the primary focus of these efforts has been to improve processes that increase uptake of home stool screening. The overall objective is to leverage these relationships and infrastructure to now focus on improving rates of timely diagnostic colonoscopy follow up after an abnormal home stool screening.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

PURPOSE AND/OR HYPOTHESIS:

The proposed study is segmented into two study Stages. Stage 1 incorporates Study Aim 1, which will use focus groups to co-develop a digital outreach intervention with Native Americans. Focus groups will help better understand how the investigators can support timely screening for colorectal cancer in this community. This IRB submission is seeking OUHSC IRB approval to conduct Stage 1. Before conducting any data collection, the investigators will seek IHS Tribal IRB approval. Once approval has been received from both OUHSC and IHS IRB, analysis of the data collected from Stage 1 will then be used to inform Stage 2. To ensure NIH funding of this grant, OUHSC IRB approval must be achieved by November 30, 2025.

Stage 2 incorporates Study Aims 2 and 3. For those aims, the investigators will test the reach, feasibility, and potential efficacy of digital outreach intervention strategies (Aim 2) and the penetration, acceptability, and scalability of the digital outreach intervention strategies (Aim 3). Dr. Neil will submit an IRB modification to both OUHSC and IHS IRBs after data analysis from Stage 1 has been completed and prior to conducting any human subjects research in Stage 2.

Native Americans (NA) endure a disproportionate burden of colorectal cancer (CRC) incidence and CRC-specific mortality. Screening is an effective early detection strategy to decrease preventable CRC-related deaths, but NA have some of the lowest CRC screening rates. In Oklahoma, only 51% of NA are up to date with screening compared to nearly two-thirds of eligible US adults. Efforts to reduce disparities in screening rates have focused on increasing access to home stool screening. However, approximately one-half of NA in Oklahoma with an abnormal home stool test do not complete a required follow-up diagnostic colonoscopy. As time to colonoscopy after an abnormal home stool test is associated with greater diagnosis of late-stage disease and CRC mortality, innovative strategies are needed to increase rates of timely diagnostic colonoscopy follow up among NA in Oklahoma. The proposed study leverages an existing relationship with the Cheyenne and Arapaho Tribes to co-develop and pilot test two digital outreach interventions to increase rates of diagnostic colonoscopy. First, mobile health outreach (mHealth; SMS text and video messages) will attempt to increase motivation to schedule a diagnostic colonoscopy. In addition to receiving informational texts about how and why to schedule a colonoscopy, participants will also receive culturally sensitive videos that use personal narratives from NA patients and other high-status Cheyenne and Arapaho Tribal members (e.g., elders). Second, current clinic workflow requires Cheyenne and Arapaho patients to visit the colonoscopy clinical facilities for both a pre-visit appointment and the actual procedure. This process requires a minimum of two round trips to a colonoscopy facility of over 90 miles for most patients. The investigators will test whether a pre-visit telehealth consultation reduces transportation barriers. Our overarching hypothesis is that culturally sensitive digital outreach intervention will increase motivation, reduce structural barriers, and, thus, improve rates of diagnostic colonoscopy.

The first study aim will co-develop culturally sensitive digital outreach intervention strategies, guided by four focus groups of NA patients (6 participants per group, with a total of 24 participants) and a community advisory board.

The second study aim will determine reach, feasibility, and potential efficacy of intervention strategies testing an mHealth outreach vs. informational pamphlet and a telehealth vs. in-person pre-visit colonoscopy consultation among 140 NA patients. The primary outcome is potential efficacy, measured as rates of diagnostic colonoscopy 60 days post-randomization. The third aim will explore penetration, acceptability, and scalability of digital outreach intervention strategies. If effective, this first-of-its-kind and highly scalable approach offers a substantial public health impact to reduce avoidable CRC morbidity and mortality among NA patients by increasing rates of diagnostic colonoscopy.

EXPERIMENTAL DESIGN:

For Stage 1, there is no experimental design.

For Stage 2, Aim 2 will use a 2 x 2 factorial design: (Outreach Type, Factor 1) mHealth outreach vs. informational pamphlet; (Consultation Type, Factor 2) telehealth vs. in-person pre-visit colonoscopy consultation. The primary outcome is potential efficacy, measured as rates of diagnostic colonoscopy 60 days post-randomization. The third aim will explore penetration, acceptability, and scalability of digital outreach intervention strategies.

PROPOSED PROCEDURE:

For Stage 1, Aim 1, the proposed procedure is broken into three Phases. Phase 1 will co-develop the mHealth Outreach (i.e., SMS texts and videos) content in 4 focus groups (n=6-8 per group) of NA from in Oklahoma that from IHS Clinton Service Unit. Groups will be stratified by history of diagnostic colonoscopy (yes/no). Phase 2 will create the mHealth outreach message library. Phase 3 will employ a community advisory board (CAB) to discuss how best to integrate mHealth and Telehealth interventions into clinic workflows.

IMPORTANCE OF KNOWLEDGE REASONABLY EXPECTED TO RESULT FROM THE RESEARCH:

The long-term goal of this collaboration is to enhance health equity through the reduction of CRC disparities in morbidity, mortality, stage-at-diagnosis, and survival among NA. To do so, the primary focus of these efforts has been to improve processes that increase uptake of colorectal cancer screening and improve rates of timely diagnostic colonoscopy follow up after an abnormal home stool screening.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

CRC Screening CRC (Colorectal Cancer)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

The two factors (Outreach Type and Consultation Type) will be crossed with one another to create a total of four experimental conditions.
Primary Study Purpose

SCREENING

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

mHealth Outreach and Telehealth Consultation

The investigators will disseminate mHealth Outreach, using SMS texts with culturally relevant language and short videos that include personal narratives of patients and high-status Tribal members, to increase motivation to a schedule a diagnostic colonoscopy.

Second, the investigators will try and overcome one refractory structural barrier to completing a diagnostic colonoscopy among Cheyenne and Arapaho Tribal members through telehealth. Cheyenne and Arapaho patients are required to visit the colonoscopy clinical facilities for both a pre-procedure appointment and the actual procedure. This process requires two round trips to a colonoscopy facility located in Lawton, OK, which is over 90 miles from the Clinton Indian Health Center. As a result, the investigators have proposed to test whether offering the pre-procedure as a telehealth consultation will overcome this transportation barriers.

Group Type EXPERIMENTAL

Digital Outreach

Intervention Type OTHER

Digital outreach interventions through focus groups. The study is based on narrative interventions that highlights culturally sensitive and values among Native American communities.

In Person Consultation

Participants randomized to In-Person Consultation will receive standard of care at IHS Lawton Hospital. Consultation includes a colonoscopy risk assessment (i.e., current medication use, risk of perforation and bleeding, ability to complete bowel prep).

Group Type ACTIVE_COMPARATOR

In Person consultation

Intervention Type OTHER

In-Person Consultation will receive standard of care at IHS Lawton Hospital. Consultation includes a colonoscopy risk assessment (i.e., current medication use, risk of perforation and bleeding, ability to complete bowel prep).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Digital Outreach

Digital outreach interventions through focus groups. The study is based on narrative interventions that highlights culturally sensitive and values among Native American communities.

Intervention Type OTHER

In Person consultation

In-Person Consultation will receive standard of care at IHS Lawton Hospital. Consultation includes a colonoscopy risk assessment (i.e., current medication use, risk of perforation and bleeding, ability to complete bowel prep).

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 45-75
* Live in Oklahoma
* Fluent in English
* Have access to email
* Identify as Native American or have a Certificate of Degree of Indian Blood

Exclusion Criteria

\-
Minimum Eligible Age

45 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Oklahoma

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jordan Neil, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Oklahoma

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

TSET Health Promotion Research Center

Oklahoma City, Oklahoma, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jordan Neil, PhD

Role: CONTACT

(405) 271-5046

Adam Alexander, PhD

Role: CONTACT

(405) 271-5046

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jan Foisy

Role: primary

405-271-5046

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

16811

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.